14+
Jahre klinische Erfahrung
4,850+
Behandelte Patienten weltweit
UK
UK-Unternehmensstruktur
190+
Peer‑Reviewed Publikationen
Integrierte neuronale Regeneration
Unser Neuro‑Rehabilitations‑ & Entwicklungsprogramm richtet sich an Patienten mit neurologischen Erkrankungen von kindlichen Entwicklungsstörungen bis zu neurodegenerativen Erkrankungen im Erwachsenenalter. Unter der Leitung von Prof. Dr. Erdal Karaöz — mit über 190 peer‑reviewten Publikationen und 4.961 Zitierungen — kombinieren wir Wharton‑Gewebe‑abgeleitete MSC‑Therapie mit einem strukturierten Rehabilitationsrahmen.
Im Gegensatz zu isolierten Behandlungen verfolgt dieses Programm einen ganzheitlichen Ansatz: prätherapeutische neurologische Evaluation, gezielte Zelltherapie, integrierte Physiotherapie und Ergotherapie sowie ein 12‑monatiges Fernüberwachungsprogramm. Unser GMP‑zertifiziertes Labor stellt sicher, dass jede Zellpräparation pharmazeutischen Qualitätsstandards entspricht.
In diesem Programm behandelte Erkrankungen
Ihre Neuro‑Rehabilitations‑Reise
Ein strukturierter, phasenweiser Ansatz zur Maximierung neurologischer Regeneration und funktioneller Verbesserung
Details des Behandlungsprotokolls
Jedes Protokoll ist personalisiert, hier jedoch ein Überblick über die therapeutischen Modalitäten unseres Neuro‑Rehabilitationsprogramms
Integrierte unterstützende Versorgung
Unser Programm geht über Zelltherapie hinaus — wir bieten umfassende Unterstützung zur Optimierung Ihrer Behandlungsergebnisse
In Großbritannien registrierte Unternehmensstruktur
StemCell Longevita operiert unter einer UK-Unternehmensstruktur und bietet internationalen Patienten die Governance‑Standards und Verbraucherschutzrechte, die sie erwarten.
- In Großbritannien registriertes Unternehmen mit voller unternehmerischer Transparenz
- Verträge unter englischem Recht zum Schutz internationaler Patienten
- Dediziertes, in Großbritannien ansässiges Koordinations‑ und Aftercare‑Team
Examples of how a review is approached
The examples below are illustrative context types — not real patients or promised results. They show the kind of questions a medical review explores and what would be monitored in different situations:
Healthy ageing
An adult with no diagnosed neurological disease asking about general cognitive wellness and recovery rather than a specific condition.
Review focus
Age-appropriate screening and whether a specific, measurable health goal exists that a discussion could reasonably address.
Monitoring
Agreed baseline markers and how they would be re-checked; no biological-age or cognitive-performance guarantees are made.
Neurological support
Someone with a specialist-managed neurological condition asking whether a regenerative approach could sit alongside their established care.
Review focus
Current diagnosis, disease activity, and treatment plan, and how any discussion would complement — not replace — neurological care.
Monitoring
Defined functional goals tracked with the home neurology team; the approach is investigational and not a substitute for established treatment.
Post-acute recovery
A medically stable person in a recovery phase after an acute neurological event or procedure, asking about supportive options.
Review focus
Confirmation that the acute phase has passed, fitness for travel, and which recovery goals can be measured alongside ongoing rehabilitation.
Monitoring
Rehabilitation progress and agreed recovery measures reviewed at structured follow-up, coordinated with the home care team.
Illustrative situations (not real patients)
Illustrative example — a 9-year-old with cerebral palsy
This is an illustrative situation type, not a real patient: a 9-year-old child with a confirmed cerebral palsy diagnosis whose family is exploring whether a regenerative discussion could sit alongside their existing rehabilitation.
Goals discussed
- Clarifying specific, measurable functional goals (for example a defined mobility, posture, or communication target) rather than a promise of recovery
- Understanding how any discussion would complement — not replace — established physiotherapy, occupational therapy, and paediatric neurology care
- Reviewing whether the child is stable enough, and travel safe enough, for an elective assessment
Caregiver role
Parents or caregivers are central to planning and follow-up: they share developmental history, imaging, therapy reports, and medication, participate in the consultation, and continue the child's established supports at home.
Monitoring
Agreed functional measures — such as recorded motor-function or mobility scales, spasticity assessments, and therapy-team observations — are tracked against a baseline with the child's home paediatric and rehabilitation team. No developmental outcome is promised.
Illustrative example — a 55-year-old with progressive MS
This is an illustrative situation type, not a real patient: a 55-year-old adult with progressive multiple sclerosis, managed by an MS neurologist, who is asking whether an investigational approach could be discussed alongside their current care.
Goals discussed
- Defining realistic, measurable goals focused on function and participation rather than reversing disease
- Understanding that MSC approaches are investigational and are not a substitute for disease-modifying therapy or rehabilitation, and are different from HSCT
- Confirming disease activity, infection risk, and travel fitness are reviewed by the MS clinician first
Caregiver role
A partner, family member, or carer helps with travel planning, medication and mobility support, and the return-home handover, and is involved in follow-up discussions.
Monitoring
Defined measures — such as a recorded disability or mobility scale, fatigue and function tracking, and any specialist-advised imaging or laboratory checks — are reviewed against a baseline with the home MS team. No slowing or reversal of progression is promised.
When a regenerative discussion is not appropriate
Regenerative approaches for neurological and developmental conditions are investigational. They are not established treatments and do not replace neurologist- or paediatrician-led care, rehabilitation, or established therapies. A discussion is not appropriate — or should be postponed or redirected — in situations such as:
- Active cancer or ongoing chemotherapy or radiation treatment
- An active systemic infection requiring urgent treatment
- Severe organ failure or medical instability that makes travel unsafe
- Uncontrolled seizures or unstable neurological or psychiatric symptoms
- Pregnancy or planned pregnancy within three months
- An expectation of a cure, guaranteed recovery, or reversal of the condition
- An undiagnosed or unexplained symptom that needs specialist assessment first
Our medical team screens for contraindications before anything is proposed. If a regenerative approach is not appropriate for the situation, we will say so honestly and suggest continuing established care.